The PPARδ agonist GW0742X reduces atherosclerosis in LDLR−/− mice
- 31 July 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 181 (1) , 29-37
- https://doi.org/10.1016/j.atherosclerosis.2004.12.028
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Decoding Transcriptional Programs Regulated by PPARs and LXRs in the MacrophageArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytesBiochemical and Biophysical Research Communications, 2003
- The Peroxisome Proliferator-Activated Receptor β/δ Agonist, GW501516, Regulates the Expression of Genes Involved in Lipid Catabolism and Energy Uncoupling in Skeletal Muscle CellsMolecular Endocrinology, 2003
- Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applicationsInternational Journal of Obesity, 2003
- The Function of the Nuclear Receptor Peroxisome Proliferator–activated Receptor Delta in Energy HomeostasisPublished by Oxford University Press (OUP) ,2003
- Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent ObesityCell, 2003
- Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generationProstaglandins & Other Lipid Mediators, 2003
- PPARδ is a very low-density lipoprotein sensor in macrophagesProceedings of the National Academy of Sciences, 2003
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transportProceedings of the National Academy of Sciences, 2001
- Activation of PPARδ alters lipid metabolism in db/db miceFEBS Letters, 2000